Is Everyone on GLP-1? Understanding the Surge in Popularity of GLP-1 Medications

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The conversation around weight loss has fundamentally shifted in recent years, largely due to the emergence of GLP-1 receptor agonist medications. What began as a diabetes treatment has evolved into a mainstream approach for weight management, with clinical trials showing average weight reductions of 15–22% over 68 weeks. PlexusDx brings this proven science to patients across all 50 states without insurance requirements or membership fees.

Why GLP-1 Medications Have Become So Popular

GLP-1 receptor agonists work by mimicking a natural hormone that regulates appetite and blood sugar, making them uniquely effective for sustained weight loss and metabolic control. Unlike older diet approaches or stimulant-based medications, GLP-1 therapy addresses the biological mechanisms driving hunger and cravings at the brain level. This mechanism has resonated with patients seeking a science-backed alternative to restrictive dieting, contributing to their rapid adoption across diverse demographics.

Media coverage, celebrity endorsements, and word-of-mouth recommendations have amplified awareness, but the real driver is clinical evidence: multiple large-scale trials demonstrate sustained weight reduction, improved cardiovascular outcomes, and better blood sugar control. Patients report reduced food preoccupation and increased energy, factors that often failed with traditional weight loss methods. The convergence of proven efficacy, improved tolerability, and growing accessibility has created unprecedented demand.

Understanding GLP-1 Receptor Agonists and How They Work

GLP-1 is a hormone your gut naturally produces in response to eating, signaling fullness to your brain and slowing stomach emptying. GLP-1 receptor agonists are medications designed to activate the same brain receptors as this natural hormone, amplifying satiety signals and reducing appetite drive. This targeted approach explains why patients often report spontaneously eating less without the willpower struggle associated with calorie restriction alone.

The medications in this class include semaglutide and tirzepatide, with tirzepatide targeting an additional receptor pathway (GIP) for enhanced metabolic effects. Both work best when paired with lifestyle changes like balanced nutrition and movement, creating a synergistic effect. PlexusDx offers both as injections and oral formulations, allowing patients to choose the delivery method that fits their preferences and lifestyle.

Who Are Good Candidates for GLP-1 Therapy

GLP-1 medications are appropriate for individuals with a BMI of 30 or higher, or BMI of 27 or higher with weight-related health conditions like hypertension or prediabetes. Beyond these conventional markers, emerging research suggests that genetic factors influence how effectively different people respond to GLP-1 versus tirzepatide therapy. PlexusDx's Precision Peptide Genetic Test identifies variants in key pathways—including GIPR, GLP1R, FTO, and MC4R—that predict individual treatment response patterns across 14 metabolic pathways.

Candidates should be motivated to maintain lifestyle changes and comfortable with injectable or oral medications taken regularly. Those with a history of certain thyroid cancers or multiple endocrine neoplasia should consult a physician before starting therapy. PlexusDx's licensed clinical team reviews each patient's health history to ensure GLP-1 treatment is appropriate and safe for their specific situation.

Access and Affordability: Why PlexusDx Stands Apart

One barrier to GLP-1 therapy has been cost, as brand-name versions can exceed $900–$1,500 per month without insurance coverage. PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A compounding pharmacies, making this evidence-based treatment accessible to patients regardless of insurance status. The company serves all 50 states with no membership fees, and HSA and FSA accounts are eligible for payment.

PlexusDx also offers oral semaglutide ($249/mo) and tirzepatide options (starting $249/mo for injection) for patients with different preferences or treatment needs. Your dose may need to go up. Your price won't—PlexusDx's flat monthly pricing means dose adjustments do not trigger price increases. For patients interested in genetic optimization, the Precision Peptide Genetic Test ($99 after the first month of treatment) maps 150+ genetic insights to personalize therapy selection and expected outcomes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Are GLP-1 medications safe for long-term use?

Clinical trials spanning 2+ years show GLP-1 receptor agonists are generally well-tolerated with manageable side effects, primarily mild gastrointestinal symptoms that often improve over time. Long-term data from cardiovascular outcome trials demonstrate sustained benefits and reduced risk of major adverse events in people with diabetes or cardiovascular disease. PlexusDx patients work with licensed clinical staff to monitor tolerability and adjust therapy as needed.

What is the difference between semaglutide and tirzepatide?

Semaglutide activates the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors, often producing greater average weight loss in clinical trials. Tirzepatide demonstrated approximately 22% weight reduction over 68 weeks compared to 15% for semaglutide in head-to-head comparisons. PlexusDx offers both as injections or oral formulations, and the Precision Peptide Genetic Test can identify which pathway may be more effective for your individual biology.

Can I stop GLP-1 medication if I reach my weight loss goal?

Weight typically returns when therapy stops because GLP-1 regulates a biological setpoint rather than causing permanent changes; continuing at a maintenance dose helps sustain results. Some patients choose to continue indefinitely, while others prefer breaks or intermittent dosing, decisions best made with your clinical provider. PlexusDx offers flexible treatment plans and ongoing clinical support to help you determine the right long-term approach for your goals.

Do I need insurance to access PlexusDx GLP-1 therapy?

No—PlexusDx serves all 50 states without requiring insurance coverage, membership fees, or prior authorization. Treatment is HSA and FSA eligible, and pricing starts at $149 per month for compounded semaglutide injections. Licensed 503A compounding pharmacies dispense all medications, and a clinical team reviews your health history before treatment begins.

How can the Precision Peptide Genetic Test improve my GLP-1 outcomes?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to different GLP-1 therapies and expected weight loss magnitude. Mapping 49 peptides across 14 pathways reveals 150+ genetic insights predicting your individual response pattern. This genetic personalization helps your PlexusDx clinician select the most effective medication and pathway for your unique biology, available for $99 after your first month of treatment.

Related Reading

• Glp 1 Medications
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications
• Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications
• Maximus Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.